Skip to main content

Botswana

Tariffs

Download data

3002.12 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions

1 tariff line

3002.12 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions
HS code Product MFN AfCFTA EFTA EU-SADC EPA SADC MERCOSUR
3002.12.00 Antisera and other blood fractions 0% – – – 0% –

Showing 1–1 of 1

HS 3002.12.00

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions

Section VI · Products of the chemical & allied industries › Ch 30 Pharmaceutical products › 30.02 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified

Close

Applied duty rates

  • 0% MFN applied rate
  • 0% SADC preferential rate
Exports | US$ thousand
  • To the world
  • Within the Commonwealth
Show data
YearTo the worldWithin the Commonwealth
2020$0$0
2021$1$1
2022$11$1
2023$2$0
2024$2$0
Imports | US$ thousand
  • From the world
  • Within the Commonwealth
Show data
YearFrom the worldWithin the Commonwealth
2020$2,377$631
2021$779$99
2022$1,682$391
2023$1,416$819
2024$1,466$749

Pilot countries

Each country has its own profile: tariff regime, export requirements, a market snapshot and links to official national portals. 

See all countries

Share this page with